Collagen formulations

Details Collagen formulations Collagen formulations

1997-09-03

1999-11-09

Webman, Edward J.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

424423, 424426, A61K 910, A61K 4742

Patent

active

059809469

ABSTRACT:
Disclosed are proteinaceous compositions comprising collagen and an effective amount of a compatible cytotoxic drug which compositions are characterized by having a single collagen transition temperature of less than about 45.degree. C. Such compositions possess enhanced retention of the cytotoxic drug at the site of injection and are optically translucent.

REFERENCES:
patent: Re33375 (1990-10-01), Luck et al.
patent: 2589210 (1952-03-01), McGinty
patent: 4177263 (1979-12-01), Rosenberg et al.
patent: 4230687 (1980-10-01), Sair et al.
patent: 4322398 (1982-03-01), Reiner et al.
patent: 4347234 (1982-08-01), Wahlig et al.
patent: 4349530 (1982-09-01), Royer
patent: 4391797 (1983-07-01), Folkman et al.
patent: 4407787 (1983-10-01), Stemberger
patent: 4424208 (1984-01-01), Wallace et al.
patent: 4536387 (1985-08-01), Sakamoto et al.
patent: 4619913 (1986-10-01), Luck et al.
patent: 4863732 (1989-09-01), Nathan et al.
patent: 5002071 (1991-03-01), Harrell
patent: 5385738 (1995-01-01), Yamahira et al.
patent: 5490984 (1996-02-01), Freed
Maugh, Science, 212:1128-1129 (1981).
Miyata, et al., Cancer Research, 43:4670-4675 (1983).
McLaughlin, et al., Cancer Research, 38:1311-1316 (1978).
Bier, et al., Cancer, 44:1194-1200 (1979).

Affiliated with

Also associated with

Rating

Collagen formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Collagen formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Collagen formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1452201